Latest News

RNA-Based Therapeutics and Vaccines

New Technologies Are Emerging to Overcome Challenges Associated with Toxicity and Drug Delivery Elina Gousseinov, Mikhail Kozlov, Claire Scanlan,Aaron Hammons,Ling Bei,Youssef Benchek,Karim Pirani,Priyabrata Pattnaik,Ruta Waghmare RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis, and certain cardiovascular con

Introducing: The Journal of Proposals, Ideas, Data, and More

There are so many scientific journals out there, it’s almost impossible for a newcomer to draw attention; but this one does. Research Ideas and Outcomes, or RIO is not just a new journal, it’s a new type of journal: it will not only publish articles, but also proposals, experimental designs, data and software. They’re open access and cover “research from all stages of the research cycle”, according to a press release they’

Phd fellowship in KU

Admission to PhD positions (full time) in President Chure Tarai-Madhesh Conservation Project isms | 19 July, 2015 20:54 Announcement for PhD positions Kathmandu University School of Sciences Admission to PhD positions (full time) in President Chure Tarai-Madhesh Conservation Project Total Number of Seats: 2   Project description: President Chure Tarai-Madhesh Conservation Development Committee Secretariat provides grant to Kathmandu Univer

New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common malignant cancer and the third leading cause of cancer death worldwide. Molecular profiling of changes in gene expression has improved our understanding of the HCC mechanism, allowing the identification of biomarkers for HCC diagnosis and HCC patient stratification for prognosis and therapy. Recently, a new group of molecules, microRNAs, has been discovered to be aberrantly expressed in HCC and some of them are functionally involved in H

BioPen to rewrite orthopaedic implants surgery

A handheld ‘bio pen’ developed in the labs of the University of Wollongong (UOW) will allow surgeons to design customised implants on-site and at the time of surgery. The BioPen, developed by researchers from the UOW-headquartered Australian Research Council Centre of Excellence for Electromaterials Science (ACES), will give surgeons greater control over where the materials are deposited while also reducing the time the patient is in surgery by delivering live cells and growth